Sachiaki Ibe
Chief Executive Officer chez ZERIA PHARMACEUTICAL CO., LTD.
Fortune : 22 M $ au 31/03/2024
Profil
Sachiaki Ibe currently works at Zeria Pharmaceutical Co., Ltd., as Chairman & Chief Executive Officer from 2014 and Tillotts Pharma AG, as Chairman.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2023 | 1 592 000 ( 3,00% ) | 22 M $ | 31/03/2024 |
Postes actifs de Sachiaki Ibe
| Sociétés | Poste | Début |
|---|---|---|
| ZERIA PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 27/06/2014 |
Tillotts Pharma AG
 Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Chairman | 05/07/2011 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZERIA PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Health Technology |
